Moshe E Gatt (Moshe Gatt, M E Gatt)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 22

Top Topics

Newly Diagnosed

Multiple Myeloma

Acute Myeloid Leukemia

Top Venues

European journal of haematology

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Shlomzion Aumann, Uria Tsubary, Boaz Nachmias, Dina Ben Yehuda, David Lavie, Neta Goldschmidt, Vladimir Vainstein, Diana Libster, Revital Saban, Adir Shaulov, Sarah Israel, Batia Avni, Sigal Grisariu, Tali Bdolah-Amram, Moshe E Gatt, Eran Zimran
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality. European journal of haematology (2023)
Vladimir Vainstein, Batia Avni, Sigal Grisariu, Shlomit Kfir-Erenfeld, Nathalie Asherie, Boaz Nachmias, Shlomtzion Auman, Revital Saban, Eran Zimran, Miri Assayag, Kalman Filanovsky, Netanel A Horowitz, Eyal Lebel, Adir Shaulov, Michal Gur, Chaggai Rosenbluh, Svetlana Krichevsky, Polina Stepensky, Moshe E Gatt
Clonal Myeloid Dysplasia Following CAR T-Cell Therapy: Chicken or the Egg? Cancers 15 (13) (2023)
Shlomzion Aumann, Uria Tsubary, Boaz Nachmias, Dina Ben Yehuda, David Lavie, Neta Goldschmidt, Vladimir Vainstein, Diana Libster, Revital Saban, Adir Shaulov, Sarah Israel, Batia Avni, Sigal Grisariu, Tali Bdolah-Amram, Moshe E Gatt, Eran Zimran
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality. European journal of haematology (2023)
Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, Paolo Milani, Foteini Theodorakakou, Shlomzion Aumann, Noa Lavi, Liat Shargian, Hila Magen, Yael Cohen, Moshe E Gatt, Iuliana Vaxman
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study. Cancers 15 (6) (2023)
Boaz Nachmias, Svetlana Krichevsky, Moshe E Gatt, Noa Gross Even-Zohar, Adir Shaulov, Arnon Haran, Shlomzion Aumann, Vladimir Vainstein
Standardization of Molecular MRD Levels in AML Using an Integral Vector Bearing ABL and the Mutation of Interest. Cancers 15 (22) (2023)
T Dubnikov Sharon, M Assayag, Batia Avni, S Kfir-Erenfeld, E Lebel, Moshe E Gatt, N Goldschmidt, Polina Stepensky, Nathalie Asherie, Sigal Grisariu
Early lymphocyte collection for anti-CD19 CART production improves T-cell fitness in patients with relapsed/refractory diffuse large B-cell lymphoma. British journal of haematology (2023)
Eyal Lebel, Efstathios Kastritis, Giovanni Palladini, Paolo Milani, Foteini Theodorakakou, Shlomzion Aumann, Noa Lavi, Liat Shargian, Hila Magen, Yael Cohen, Moshe E Gatt, Iuliana Vaxman
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World Study. Cancers 15 (6) (2023)
Shlomzion Aumann, Uria Tsubary, Boaz Nachmias, Dina Ben Yehuda, David Lavie, Neta Goldschmidt, Vladimir Vainstein, Diana Libster, Revital Saban, Adir Shaulov, Sarah Israel, Batia Avni, Sigal Grisariu, Tali Bdolah-Amram, Moshe E Gatt, Eran Zimran
Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality. European journal of haematology (2023)
Vaishali Sanchorawala, Giovanni Palladini, Monique C Minnema, Arnaud Jaccard, Hans C Lee, Simon Gibbs, Peter Mollee, Christopher P Venner, Jin Lu, Stefan Schönland, Moshe E Gatt, Kenshi Suzuki, Kihyun Kim, María Teresa Cibeira, Meral Beksac, Edward Libby, Jason Valent, Vania Tietsche de Moraes Hungria, Sandy W Wong, Michael Rosenzweig, Naresh Bumma, Dominique Chauveau, Katharine S Gries, John Fastenau, Nam Phuong Tran, Xiang Qin, Sandra Y Vasey, Brendan M Weiss, Jessica Vermeulen, Kai Fai Ho, Giampaolo Merlini, Raymond L Comenzo, Efstathios Kastritis, Ashutosh D Wechalekar
Health-related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study. American journal of hematology 97 (6) (2022)
Noa Gross Even-Zohar, Marjorie Pick, Liron Hofstetter, Adir Shaulov, Boaz Nachmias, Eyal Lebel, Moshe E Gatt
CD24 Is a Prognostic Marker for Multiple Myeloma Progression and Survival. Journal of clinical medicine 11 (10) (2022)
Eyal Lebel, Boaz Nachmias, Marjorie Pick, Noa Gross Even-Zohar, Moshe E Gatt
Understanding the Bioactivity and Prognostic Implication of Commonly Used Surface Antigens in Multiple Myeloma. Journal of clinical medicine 11 (7) (2022)
Shlomit Kfir-Erenfeld, Nathalie Asherie, Sigal Grisariu, Batia Avni, Eran Zimran, Miri Assayag, Tatyana Dubnikov Sharon, Marjorie Pick, Eyal Lebel, Adir Shaulov, Yael C Cohen, Irit Avivi, Cyrille J Cohen, Polina Stepensky, Moshe E Gatt
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (23) (2022)
Tamir Shragai, Hila Magen, Noa Lavi, Moshe E Gatt, Svetlana Trestman, Miri Zektser, Chezi Ganzel, Osnat Jarchowsky, Tamar Berger, Tamar Tadmor, Merav Leiba, Katrin Hertzog-Tzarfaty, Netanel Horowitz, Michael Shapira, David Varssano, Yoav Berger, Shahar Frenkel, Mark Krauthammer, Irit Avivi, Efrat Luttwak, Yael C Cohen, null null
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study. British journal of haematology (2022)
Dean Yogev, Marjorie Pick, Elena Slyusarevsky, Galina Pogrebijski, Anna Pickin, Moshe E Gatt
Serum Hevylite® assay in the differential diagnosis of patients with high suspicion of AL Amyloidosis. International journal of laboratory hematology 43 (3) (2021)
Eirini Katodritou, Efstathios Kastritis, Moshe E Gatt, Yael C Cohen, Irit Avivi, Anastasia Pouli, Chrysavgi Lalayianni, Noa Lavi, Sosana Delimpasis, Marie-Christine Kyrtsonis, Michalis Michael, Celia Suriu, Zektser Miri, Katrin Tzafarti, Chrysanthi Vadikoliou, Dimitris Maltezas, Panagiotis Zikos, Chezi Ganzel, Yuliana Vaxman, Ariel Aviv, Anna Christoforidou, Maria Gavriatopoulou, Adir Shaulov, Evgenia Verrou, Aristea-Maria Papanota, Gabriel Fakinos, Annita-Ioanna Gkioka, Vasiliki Palaska, Theodora Triantafyllou, Pavlina Konstantinidou, Achilles Anagnostopoulos, Evangelos Terpos, Meletios- Athanasios Dimopoulos
Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group. American journal of hematology 95 (5) (2020)
Paul Gerard Richardson, Arnon Nagler, Dina Ben-Yehuda, Ashraf Badros, Parameswaran N Hari, Roman Hájek, Ivan Spicka, Hakan Kaya, Richard LeBlanc, Sung-Soo Yoon, Kihyun Kim, Joaquin Martinez-Lopez, Moshe Mittelman, Ofer Shpilberg, Paul Blake, Teru Hideshima, Kathleen Colson, Jacob P Laubach, Irene M Ghobrial, Merav Leiba, Moshe E Gatt, Peter Sportelli, Michael Chen, Kenneth C Anderson
Randomized, placebo-controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated with bortezomib. EJHaem 1 (1) (2020)
Tamir Shragai, Moshe E Gatt, Noa Lavie, Iuliana Vaxman, Tamar Tadmor, Ory Rouvio, Miri Zektser, Nethanel Horowitz, Hila Magen, Mouna Ballan, Celia Suru, Efrat Luttwak, Shai Levi, Tomer Ziv-Baran, Irit Avivi, Yael C Cohen
Daratumumab for relapsed AL amyloidosis-When cumulative real-world data precedes clinical trials: A multisite study and systematic literature review. European journal of haematology 106 (2) (2020)
Yishai Ofran, Michal Hayun, Ronit Leiba, Tsila Zukerman, Netanel A Horowitz, Ron Hoffman, Shimrit Ringelstein, Noa Lavi, Avraham Frisch, Israel Henig, Moshe E Gatt, Ilana Hellmann, Ariela Arad, Shlomo Bulvik, Ron Ram, Sharon Gino-Moor, Revital Saban, Ariella Tvito, Jacob M Rowe, Chezi Ganzel
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study. American journal of hematology 95 (1) (2019)
Yael C Cohen, Avi Saranga, Moshe E Gatt, Noa Lavi, Chezi Ganzel, Hila Magen, Irit Avivi, Tamar Tadmor, Celia Suriu, Osnat Jarchowsky Dolberg, Amitai Papushado, Svetlana Trestman, Ron Ram
Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective study. American journal of hematology 93 (6) (2018)
Moshe E Gatt, Batia Kaplan, Dean Yogev, Elana Slyusarevsky, Galina Pogrebijski, Sizilia Golderman, Olga Kukuy, Avi Livneh
The use of serum free light chain dimerization patterns assist in the diagnosis of AL amyloidosis. British journal of haematology 182 (1) (2018)
Marjorie Pick, Vladimir Vainstein, Neta Goldschmidt, David Lavie, Diana Libster, Alexander Gural, Sigal Grisariu, Batia Avni, Dina Ben Yehuda, Moshe E Gatt
Daratumumab resistance is frequent in advanced-stage multiple myeloma patients irrespective of CD38 expression and is related to dismal prognosis. European journal of haematology 100 (5) (2018)
Adir Shaulov, Irit Avivi, Yael C Cohen, Adrian Duek, Merav Leiba, Moshe E Gatt
Gastrointestinal perforation in light chain amyloidosis in the era of novel agent therapy - a case series and review of the literature. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 25 (1) (2017)